A recent study suggests that IRX3 is a functional long-range target of obesity-associated variants within FTO, and represents a novel determinant of body mass and composition; however, they do not dispute the idea emerging from animal studies that FTO is also a regulator of body mass and composition (Smemo et al., 2014). This evidence concerns the gene FTO and obesity disorder.